Skip to main content
Ustekinumab Coupon - Ustekinumab 1ml of 90mg/ml syringe

ustekinumab

Generic Stelara
Used for Crohn's Disease, Plaque Psoriasis, Psoriatic Arthritis, Ulcerative Colitis

Stelara (ustekinumab) is an injectable medication used to treat autoimmune conditions like plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. As an interleukin antagonist, it works by blocking certain proteins that cause inflammation in your body, which helps reduce swelling and ease symptoms. You typically get it as an injection under your skin. Common side effects include common cold symptoms, headache, and feeling tired. This medication also has many biosimilars available.

Reviewed by:Last reviewed on June 11, 2025
basics-icon

What is Stelara (ustekinumab)?

What is Stelara (ustekinumab) used for?

How Stelara (ustekinumab) works

Stelara (ustekinumab) is an interleukin antagonist. It works by blocking two proteins in your immune system — interleukin-12 (IL-12) and interleukin-23 (IL-23) — that play a major role in inflammation. By targeting these proteins, the medication helps to lower inflammation and relieve symptoms from autoimmune conditions.

Drug facts

Common BrandsStelara
Drug ClassIL-12 and IL-23 antagonist
Controlled Substance ClassificationNot a controlled medication
Generic StatusLower-cost generic available
AvailabilityPrescription only
side-effects-icon

Side effects of Stelara (ustekinumab)

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

Plaque psoriasis

  • Common cold symptoms (7-8%)
  • Upper respiratory tract infection (4-5%)
  • Headache (5%)

Psoriatic arthritis

  • Joint pain (3%)
  • Nausea (3%)

Crohn's disease

  • Common cold symptoms (11%)
  • Redness at the injection site (5%)
  • Yeast infection (5%)
  • Bronchitis (5%)

Ulcerative colitis:

  • Common cold symptoms (24%)
  • Headache (10%)
  • Stomach pain (7%)
  • Flu infection (6%)
  • Fever (5%)

Less Common Side Effects

  • Dizziness
  • Diarrhea
  • Back pain
  • Muscle pain
  • Depression
  • Sore throat
  • Itchiness
  • Vomiting

Stelara (ustekinumab) serious side effects

Contact your healthcare provider immediately if you experience any of the following.

  • Serious infection: fever, muscle aches, cough, trouble breathing, weight loss, sores on the body, diarrhea, stomach pain, problems with urination, tiredness
  • Severe allergic reaction: feeling faint, facial swelling, chest tightness, rash
  • Brain condition: headache, confusion, vision problems, seizures
  • Lung conditions: trouble breathing, cough

Source: DailyMed

The following Stelara (ustekinumab) side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Change in your skin, such as a new growth, a sore that doesn't heal, or a change in a mole
  • Dry cough, shortness of breath or trouble breathing
  • Infection—fever, chills, cough, sore throat, wounds that don't heal, pain or trouble when passing urine, general feeling of discomfort or being unwell
  • Sudden and severe headache, confusion, change in vision, seizures, which may be signs of posterior reversible encephalopathy syndrome (PRES)

Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):

prices-container

Get your GoodRx coupon

Avg retail price
N/A
GoodRx discount
$211.60
See prices
pros-and-cons-icon

Pros and cons of Stelara (ustekinumab)

Pros

  • After the first few doses, only need a shot every 8 to 12 weeks
  • Available as a prefilled syringe or vial
  • Syringes can be stored at room temperature for up to 30 days
  • Approved for children as young as 6 years old

Cons

  • Can weaken your immune system and raise your risk of infection
  • Potential to cause serious allergic reactions
  • For CD and UC, the first dose must be given as an IV infusion
  • Can't receive live vaccines while taking this medication
pharmacist-tips-icon

Pharmacist tips for Stelara (ustekinumab)

pharmacist
  • Mark your injection dates on a calendar. You don’t use Stelara (ustekinumab) very often, so it can be easy to forget. Keeping track helps you stay on schedule.
  • Inject Stelara (ustekinumab) under the skin in your upper arms, thighs, buttocks, or stomach area. Pick a new spot each time to avoid skin irritation. Don’t inject into skin that’s red, bruised, sore, or hard.
  • Get medical help right away if you have signs of a serious allergic reaction after using Stelara (ustekinumab). These might include swelling of the face or throat, trouble breathing, or a rash.
  • Tell your prescriber if you have a latex allergy. The needle cover of the Stelara (ustekinumab) prefilled syringe contains latex which could cause a reaction if you're sensitive to it.
  • Stelara (ustekinumab) can weaken your immune system, making it harder to fight infections. Let your prescriber know if you have symptoms of an infection, such as a fever, cough, tiredness, muscle aches, or stomach pain.
  • Contact your care team right away if you notice symptoms like headache, confusion, vision problems, or seizures. These could be signs of a rare brain condition linked to Stelara (ustekinumab).
  • Stelara (ustekinumab) can affect how your body responds to vaccines. Avoid live vaccines during treatment. Talk to your prescriber before getting any type of vaccine.
  • Store Stelara (ustekinumab) in its original carton in the refrigerator. If you're using the prefilled syringes, you can keep them at room temperature (up to 30°C or 86°F) for up to 30 days, but don’t put them back once they've been out of the fridge. If you’re using a vial, it should stay refrigerated until it’s time for your dose.

How to inject Stelara (ustekinumab) from a prefilled syringe:

  • Make sure you know how to inject Stelara (ustekinumab) the right way. Ask your prescriber or pharmacist if you have questions.
  • Clean the spot on your skin with an alcohol wipe before you inject to help prevent infection.
  • When you're ready to inject, take off the needle cover from the syringe. Hold the syringe with one hand and pinch the cleaned skin with the other.
  • Insert the needle into the pinched skin at about a 45-degree angle and push the plunger down with your thumb until all the liquid is injected. Then take out the needle and let go of your skin.
  • Put the syringe into a sharps container. Never throw used syringes into the regular trash since it could harm someone.
warnings-icon

Risks and warnings for Stelara (ustekinumab)

Stelara (ustekinumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

Infections

  • Risk factors: Active, chronic, or recurrent infection | People with certain genetic mutations | Taking other medications that weaken your immune system

Stelara (ustekinumab) can raise your risk of infections, including serious ones that might need hospital care. These can be caused by bacteria, viruses, or fungi. Tell your prescriber about your medical history before starting Stelara (ustekinumab), especially if you've ever had tuberculosis (TB). Let your care team know right away if you have signs of infection, such as fever, chills, cough, or tiredness — your treatment might need to be paused until you recover.

Cancers

  • Risk factors: Older adults | Taking other medications that weaken your immune system | History of skin cancer

Stelara (ustekinumab) weakens your immune system and can raise your risk of certain cancers. Some people developed skin cancer while taking this medication, especially those with a higher risk. Your care team will check your skin regularly during treatment, particularly if you have a history of cancer or other risk factors. Let your prescriber know if you’ve had cancer before or if you notice any new or changing spots on your skin.

Severe allergic reaction

Serious allergic reactions, including anaphylaxis and angioedema, have been reported with Stelara (ustekinumab). If you have a severe reaction, your care team will stop the medication and treat you right away. Get medical help immediately if you have symptoms like trouble breathing, swelling of your face or throat, or a serious rash.

Brain condition

Rare cases of a brain condition called posterior reversible encephalopathy syndrome (PRES) have been reported in people taking Stelara (ustekinumab). Symptoms can include headache, seizures, confusion, or vision changes. These symptoms can appear anywhere from a few days to months after starting the medication, sometimes even after a year or more. If you have PRES, your care team will stop the medication and provide treatment. Let your prescriber know right away if you notice any of these signs.

Vaccines

Before starting Stelara (ustekinumab), you or your child should be up to date on all recommended vaccines. While you're being treated, avoid getting live vaccines. You should also avoid the BCG vaccine during treatment, as well as for one year before starting and one year after stopping the medication. Be careful if someone in your household gets a live vaccine since it can spread and pose a risk to you. Non-live vaccines are generally safe, but they might not work as well while you're taking Stelara (ustekinumab). Check with your care team before getting any vaccines during treatment.

Lung problems

Different types of pneumonia have been reported in people taking Stelara (ustekinumab), and in some cases, these conditions were serious. Symptoms can include cough and trouble breathing. Let your care team know right away if you have new or worsening breathing problems. You might have to stop taking the medication and receive the appropriate treatment.

dosage-icon

Stelara (ustekinumab) dosage

The average cost for 1 syringe of 1ml of 90mg/ml of Stelara (ustekinumab) is $7,005.48 with a free GoodRx coupon. This is 41.10% off the average retail price of $11,893.20.
syringeSyringe
DosageQuantityPrice as low asPrice per unit
0.5ml of 45mg/0.5ml1 syringe$3,507.24$3,507.24
1ml of 90mg/ml1 syringe$7,005.48$7,005.48
vialVial
DosageQuantityPrice as low asPrice per unit
0.5ml of 45mg/0.5ml1 vial$10,512.72$10,512.72

Typical dosage for Stelara (ustekinumab)

Plaque psoriasis

  • Adults:
    • Weight 220 lbs or less: The typical dose is 45 mg injected under the skin once, then another 45 mg four weeks later. After the second dose, 45 mg is injected every 12 weeks.
    • Weight more than 220 lbs: The typical dose is 90 mg injected under the skin once, then another 90 mg four weeks later. After the second dose, 90 mg is injected every 12 weeks.
  • Children ages 6 and older:
    • Weight less than 132 lbs: The typical dose is 0.75 mg/kg of body weight injected under the skin once, then another 0.75 mg/kg four weeks later. After the second dose, 0.75 mg/kg is injected every 12 weeks.
    • Weight of 132 lbs to 220 lbs: The typical dose is 45 mg injected under the skin once, then another 45 mg four weeks later. After the second dose, 45 mg is injected every 12 weeks.
    • Weight more than 220 lbs: The typical dose is 90 mg injected under the skin once, then another 90 mg four weeks later. After the second dose, 90 mg is injected every 12 weeks.

Psoriatic arthritis

  • Adults:
    • Psoriatic arthritis only: The typical dose is 45 mg injected under the skin once, then another 45 mg four weeks later. After the second dose, 45 mg is injected every 12 weeks.
    • Psoriatic arthritis with plaque psoriasis and weighing more than 220 lbs: The typical dose is 90 mg injected under the skin once, then another 90 mg four weeks later. After the second dose, 90 mg is injected every 12 weeks.
  • Children ages 6 and older:
    • Weight less than 132 lbs: The typical dose is 0.75 mg/kg of body weight injected under the skin once, then another 0.75 mg/kg four weeks later. After the second dose, 0.75 mg/kg is injected every 12 weeks.
    • Weight of 132 lbs or more: The typical dose is 45 mg injected under the skin once, then another 45 mg four weeks later. After the second dose, 45 mg is injected every 12 weeks.
    • Psoriatic arthritis with plaque psoriasis and weighing more than 220 lbs: The typical dose is 90 mg injected under the skin once, then another 90 mg four weeks later. After the second dose, 90 mg is injected every 12 weeks.

Crohn's disease and ulcerative colitis:

  • Adults:
    • Weight less than 121 lbs: The typical dose is 260 mg infusion into the veins once, then 90 mg injected under the skin every 8 weeks.
    • Weight of 121 lbs to 187 lbs: The typical dose is 390 mg infusion into the veins once, then 90 mg injected under the skin every 8 weeks.
    • Weight more than 187 lbs: The typical dose is 520 mg infusion into the veins once, then 90 mg injected under the skin every 8 weeks.
cost-icon

How much does Stelara (ustekinumab) cost?

To access savings, use a GoodRx coupon and pay just a fraction of the retail price.
Ustekinumab-ttwe (Pyzchiva) (brand)
GoodRx lowest price

$211.60

Stelara (ustekinumab) (generic)
GoodRx lowest price

$211.60

alternatives-icon

What are alternatives to Stelara (ustekinumab)?

There are a number of medications that your doctor can prescribe in place of Stelara (ustekinumab). Compare a few possible alternatives below.
Stelara (ustekinumab)
Used for:
$211.60Lowest GoodRx priceView prices
Used for:
$0.00Lowest GoodRx priceView prices
Used for:
$20,217.99Lowest GoodRx priceView prices
latest-news-icon

News about Stelara (ustekinumab)

images-icon

Stelara (ustekinumab) images

yellow - Ustekinumab 90mg/mL Prefilled Syringe Solution for Injection
This medicine is Yellow Syringe.yellow - Ustekinumab 90mg/mL Prefilled Syringe Solution for Injection

References

Best studies we found

Aggeletopoulou, I., et al. (2018). Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease. World Journal of Gastroenterology.

American College of Allergy, Asthma & Immunology. (n.d.). Latex allergy.

Feagan, B. G., et al. (2016). Ustekinumab as induction and maintenance therapy for Crohn’s disease. The New England Journal of Medicine.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.